Biotech

All Articles

Roche discards $120M tau possibility, returning legal rights to UCB

.Roche has sent back the rights to UCB's anti-tau antibody bepranemab, ignoring a $120 million bank ...

Editas boosts in vivo approach via $238M Genenvant contract

.Editas Medicines has signed a $238 thousand biobucks deal to combine Genevant Scientific research's...

Combo outcomes, Vicodin miss out on and also stellar safety

.Tip has disclosed stage 3 records on its own near-approval pain medicine applicant suzetrigine, cla...

Angelini pens $360M biobucks pact for ph. 1 human brain condition drug

.Italy's Angelini Pharma has signed a $360 thousand biobucks contract centered on a phase 1-stage mi...

Sage gives up fifty percent of R&ampD group and shakes up C-suite again

.Sage Therapeutics' latest attempt to shrink its pipe as well as labor force will find a third of th...

With period 1 information, Mood possesses an eye on early-stage bladder cancer

.Along with its own lead prospect in a stage 3 trial for a rare eye cancer, Aura Biosciences is actu...

Less than a year in, BenevolentAI CEO is actually out-- Chutes &amp Ladders

.Accept to recently's Chutes &amp Ladders, our roundup of substantial management hirings, shootings ...

Roche MAGE-A4 trial taken out after important evaluation

.Roche has actually produced another MAGE-A4 system vanish, taking out a stage 1 trial of a T-cell b...

FDA places predisposed hold on BioNTech-OncoC4 period 3 test

.The FDA has applied a partial hang on a period 3 non-small tissue lung cancer practice run through ...

REGiMMUNE, Kiji merge to develop Treg 'incredibly business,' strategy IPO

.Taiwan's REGiMMUNE as well as Europe-based Kiji Therapies are merging to make a worldwide minded re...